Myeloid neoplasms after breast cancer: “therapy-related” not an independent poor prognostic factor

References

• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
   PubMed Web of Science ®Google Scholar
• Schoch C, Kern W, Schnittger S, et al. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004;18:120–125.
   PubMed Web of Science ®Google Scholar
• Josting A, Wiedenmann S, Franklin J, et al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003;21:3440–3446.
   PubMed Web of Science ®Google Scholar
• Wheatley K, Brookes CL, Howman AJ, et al. Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. Br J Haematol 2009;145:598–605.
   PubMed Web of Science ®Google Scholar
• Feldman EJ. Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants? Best Pract Res Clin Haematol 2011;24:523–526.
   PubMed Web of Science ®Google Scholar
• Ostgard LS, Kjeldsen E, Holm MS, et al. Reasons for treating secondary AML as de novo AML. Eur J Haematol 2010;85:217–226.
   PubMed Web of Science ®Google Scholar
• Kern W, Haferlach T, Schnittger S, et al. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 2004;22:2510–2511.
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Andersen MK, Andersen MT, et al. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008;22:240–248.
   PubMed Web of Science ®Google Scholar
• Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102:43–52.
   PubMed Web of Science ®Google Scholar
• Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748–1757.
   PubMed Web of Science ®Google Scholar
• Abdelhameed A, Pond GR, Mitsakakis N, et al. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation. Cancer 2008;112:1513–1521.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642–4649.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Greenberg PL, Bennett JM, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006;108:419–425.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453–474.
   PubMed Web of Science ®Google Scholar
• Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007;25:1908–1915.
   PubMed Web of Science ®Google Scholar
• Nardi V, Winkfield KM, Ok CY, et al. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. J Clin Oncol 2012;30:2340–2347.
   PubMed Web of Science ®Google Scholar
• Beaumont M, Sanz M, Carli PM, et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003;21:2123–2137.
   PubMed Web of Science ®Google Scholar
• Quesnel B, Kantarjian H, Bjergaard JP, et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993;11:2370–2379.
   PubMed Web of Science ®Google Scholar
• Detourmignies L, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol 1992;10:1430–1435.
   PubMed Web of Science ®Google Scholar
• AML 17: Acute myeloid leukemia clinical trial 17. Available from: http://aml17.cardiff.ac.uk/files/files.htm
   Google Scholar
• Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325–345.
   PubMed Web of Science ®Google Scholar
• Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia 2002;16:2366–2378.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Gonzalez JD, Gonzalez J, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy. J Clin Oncol 2010;28:3872–3879.
   PubMed Web of Science ®Google Scholar
• Kayser S, Dohner K, Krauter J, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 2011;117:2137–2145.
   PubMed Web of Science ®Google Scholar
• Allan JM, Travis LB. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005;5:943–955.
   PubMed Web of Science ®Google Scholar
• Seedhouse C, Russell N. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br J Haematol 2007;137:513–529.
   PubMed Web of Science ®Google Scholar
• Knight JA, Skol AD, Shinde A, et al. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood 2009;113:5575–5582.
   PubMed Web of Science ®Google Scholar
• Leone G, Fianchi L, Voso MT. Therapy-related myeloid neoplasms. Curr Opin Oncol 2011;23:672–680.
   PubMed Web of Science ®Google Scholar
• Larson RA. Therapy-related myeloid neoplasms. Haematologica 2009;94:454–459.
   PubMed Web of Science ®Google Scholar
• Czader M, Orazi A. Therapy-related myeloid neoplasms. Am J Clin Pathol 2009;132:410–425.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Reddy CA, Ciezki JP, et al. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation. J Natl Cancer Inst 2014;106:djt462.
   PubMed Web of Science ®Google Scholar
• Martin MG, Welch JS, Luo J, et al. Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study. Breast Cancer Res Treat 2009;118:593–598.
   PubMed Web of Science ®Google Scholar